High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways

Cancer Research

Volumn 67, Issue 5, 2007, Pages 2373-2381

  Yaglom, Julia A ^a   Gabai, Vladimir L ^a   Sherman, Michael Y ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; CYCLIN DEPENDENT KINASE 1; DNA; HEAT SHOCK PROTEIN 72; P21 ACTIVATED KINASE; PROTEIN MDM2; PROTEIN P53; RETROVIRUS VECTOR; SMALL INTERFERING RNA; TEMSIROLIMUS;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SENESCENCE; STRESS;

CELL AGING; DNA DAMAGE; HCT116 CELLS; HELA CELLS; HSP72 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS; PROTEOME; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33947267567     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3796     Document Type: Article

References (36)

1. Nollen EA, Brunsting JF, Roelofsen H, Weber LA, Kampinga HH. In vivo chaperone activity of heat shock protein 70 and thermotolerance. Mol Cell Biol 1999;19: 2069-79.
2. Beere HM. "The stress of dying": the role of heat shock proteins in the regulation of apoptosis. J Cell Sci 2004; 117:2641-51.
3. Gabai VL, Sherman MY. Hsp72 and cell signalling. In: Henderson B. Pockley AG, editors. Molecular chaperones and cell signalling. Cambridge: Cambridge University Press; 2005. p. 144-59.
4. Gabai VL, Meriin AB, Mosser DD, et al. HSP70 prevent activation of stress kinases: a novel pathway of cellular thermotolerance. J Biol Chem 1997;272:18033-7.
5. Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 1997;17:5317-27.
6. Jaattela M. Escaping cell death: survival proteins in cancer [Review]. Exp Cell Res 1999;248:30-43.
7. Jolly C, Morimoto RJ. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000;92:1564-72.
8. Mosser D, Morimoto RI. Molecular chaperones and the stress of oncogenesis. Oncogene 2004;23:2907-18.
9. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005;10:86-103.
10. Hwang TS, Han HS, Choi HK, et al. Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J Gastroenterol Hepatol 2003;18:690-700.
11. Volm M, Koomagi R, Mattern J, Efferth T. Protein expression profile of primary human squamous cell lung carcinomas indicative of the incidence of metastases. Clin Exp Metastasis 2002;19:385-90.
12. Jaattela M. Over-expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells. Int J Cancer 1995; 60:89-93.
13. Seo J, Park YM, Kim JI, et al. T cell lymphoma in transgenic mice expressing the human Hsp70 gene. Biochem Biophys Res Commun 1996;218:582-7.
14. Volloch VZ, Sherman MY. Oncogenic potential of Hsp72. Oncogene 1999;18:3648-51.
15. Kabakov AE, Gabai VL. Heat shock proteins and cytoprotectiom ATP-deprived mammalian cells. Austin (TX): R.G. Landes Co; 1997.
16. Jaatella M, Wissing D, Bauer PA, Li GC. Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J 1992;11:3507-12.
17. Clemons NJ, Buzzard K, Steel R, Anderson RL. Hsp72 inhibits Fas-mediated apoptosis upstream of the mitochondria in type II cells. J Biol Chem 2005;280: 9005-12.
18. Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F, Jaattela M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci U S A 2000;97:7871-6.
19. Nylandsted J, Wick W, Hirt UA, et al. Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. Cancer Res 2002;62: 7139-42.
20. Nylandsted J, Gyrd-Hansen M, Danielewicz A, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 2004;200:425-35.
21. Gabai VL, Budagova KR, Sherman MY. Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene 2005;24:3328-38.
22. Roninson IB. Tumor cell senescence in cancer treatment Cancer Res 2003;63:2705-15.
23. Schmitt CA, Fridman JS, Yang M, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002;109:335-46.
24. Rohde M, Daugaard M, Jensen MH, Helin K, Nylandsted J, Jaattela M. Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev 2005;19:570-82.
25. Dimri G, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995;92:9363-7.
26. Meriin AB, Yaglom JA, Gabai VL, Mosser DD, Zon L, Sherman MY. Protein damaging stresses activate JNK via inhibition of its phosphatase: a novel pathway controlled by Hsp72. Mol Cell Biol 1999;19:2547-55.
27. Kahlem P, Dorken B, Schmitt CA. Cellular senescence in cancer treatment: friend or foe? J Clin Invest 2004; 113:169-74.
28. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001;292:1552-5.
29. Masutomi K, Possemato R, Wong JMY, et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci USA 2005;102:8222-7.
30. Stommel JW, Wahl GM. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. EMBO J 2004;23:1547-56.
31. Burri N, Shaw P, Bouzourene H, et al. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab Invest 2001;1:217-29.
32. Wada T, Joza N, Cheng H-yM, et al. MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence. Nat Cell Biol 2004;6:215-26.
33. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73:39-85.
34. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. Disruption of the ARF-Mdm2-53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 1999;13:2658-69.
35. Michael D, Oren M. The p53-2 module and the ubiquitin system. Semin Cancer Biol 2003;13:49-58.
36. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ 2003;10:431-42.